- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Synageva BioPharma Corp+ Add to Watchlist
GEVA:US79.3600 USD 0.8700 1.08%
As of 20:10:00 ET on 07/11/2014.
Company Profile for Synageva BioPharma Corp (GEVA)
Synageva BioPharma Corp. is a clinical stage biopharmaceutical company. The Company is focused on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and unmet medical need.
Synageva BioPharma Corp
Key Executives for Synageva BioPharma Corp (GEVA)
|Sanj K PatelPresident/CEO/Secretary||Carsten BoessSenior VP/CFO|
|Glen WilliamsSenior VP:Global Technical Ops||Marc E GoldbergSenior VP:Product Dev|